New research from the University of Minnesota Medical School has discovered critical mutations in molecules implicated in obesity, which may help inform the development of new anti-obesity therapies.
The University of Minnesota Medical School is at the forefront of developing a cell-based therapy for Duchenne muscular dystrophy (DMD).
Dr. Bernadette Gillick has received an R21 Exploratory/Developmental grant from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health & Human Development.
Cytomegalovirus or CMV is a common virus that infects people of all ages. Over half of adults by age 40 have been infected with CMV.
August is National Immunization Awareness Month, which is held every year to highlight the importance of vaccination for people of all ages.
The five year project aims to study an enzyme-driven mutation process in breast cancer cells.
Study demonstrates that network-level brain activity can detect specific types of mental effort.
Researchers at the University of Minnesota Medical School’s Department of Surgery and Schulze Diabetes Institute have maintained long-term survival and function of pancreatic islet transplants despite complete discontinuation of all anti-rejection drugs on day 21 after the transplant.
Researchers found a link between inherited mutations in the BRCA gene and prostate cancer.
Dr. Emil Lou and his research team demonstrated that proteins derived from the oncogene KRAS have the ability to transfer between colon cancer cells via long cellular skyway-like extensions called ‘tunneling nanotubes’.